Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001565152 | SCV001788440 | uncertain significance | not provided | 2024-12-02 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005237905 | SCV005886007 | uncertain significance | not specified | 2025-02-18 | criteria provided, single submitter | clinical testing | Variant summary: MYO7A c.64G>T (p.Val22Leu) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8.2e-06 in 244926 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.64G>T in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1200213). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Natera, |
RCV001832770 | SCV002093098 | uncertain significance | Usher syndrome type 1B | 2020-10-13 | no assertion criteria provided | clinical testing |